Serum HE4 as a diagnostic and prognostic marker for lung cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 4, 2012, Pages 1141-1149

  Iwahori, Kota ^a   Suzuki, Hidekazu ^b   Kishi, Yoshiro ^b   Fujii, Yoshihiro ^b   Uehara, Rie ^b   Okamoto, Norio ^b   Kobayashi, Masashi ^b   Hirashima, Tomonori ^b   Kawase, Ichiro ^b   Naka, Tetsuji ^b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN; TUMOR MARKER; WFDC2 PROTEIN, HUMAN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; OVARY TUMOR; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; TREATMENT OUTCOME; TUMOR CELL LINE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; PROTEINS; REFERENCE VALUES; ROC CURVE; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 85027930359     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0356-9     Document Type: Article

References (0)